B Bilgin Global Mod Global Mod 5 Ağu 2022 #1 JB Pharma’s revenue surges 30% in Q1, PAT declines JB Pharma’s domestic formulations business grew at 34% in Q1, while international business revenue rose 28%
JB Pharma’s revenue surges 30% in Q1, PAT declines JB Pharma’s domestic formulations business grew at 34% in Q1, while international business revenue rose 28%
